Supplementary Figure S2 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality

Abstract

<p>Clinical outcomes based on grade II-IV acute GVHD or frequency of circulating CD83, CD4 T cells</p>